GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Blau Farmaceutica SA (BSP:BLAU3) » Definitions » ROA %

Blau Farmaceutica (BSP:BLAU3) ROA % : 3.61% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Blau Farmaceutica ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Blau Farmaceutica's annualized Net Income for the quarter that ended in Dec. 2023 was R$111 Mil. Blau Farmaceutica's average Total Assets over the quarter that ended in Dec. 2023 was R$3,064 Mil. Therefore, Blau Farmaceutica's annualized ROA % for the quarter that ended in Dec. 2023 was 3.61%.

The historical rank and industry rank for Blau Farmaceutica's ROA % or its related term are showing as below:

BSP:BLAU3' s ROA % Range Over the Past 10 Years
Min: 9   Med: 21.68   Max: 30.26
Current: 9.16

During the past 8 years, Blau Farmaceutica's highest ROA % was 30.26%. The lowest was 9.00%. And the median was 21.68%.

BSP:BLAU3's ROA % is ranked better than
81.72% of 1083 companies
in the Drug Manufacturers industry
Industry Median: 1.72 vs BSP:BLAU3: 9.16

Blau Farmaceutica ROA % Historical Data

The historical data trend for Blau Farmaceutica's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Blau Farmaceutica ROA % Chart

Blau Farmaceutica Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROA %
Get a 7-Day Free Trial 30.05 25.29 18.06 15.06 9.00

Blau Farmaceutica Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.38 8.30 11.32 14.27 3.61

Competitive Comparison of Blau Farmaceutica's ROA %

For the Drug Manufacturers - Specialty & Generic subindustry, Blau Farmaceutica's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Blau Farmaceutica's ROA % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Blau Farmaceutica's ROA % distribution charts can be found below:

* The bar in red indicates where Blau Farmaceutica's ROA % falls into.



Blau Farmaceutica ROA % Calculation

Blau Farmaceutica's annualized ROA % for the fiscal year that ended in Dec. 2023 is calculated as:

ROA %=Net Income (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=249.809/( (2499.048+3053.528)/ 2 )
=249.809/2776.288
=9.00 %

Blau Farmaceutica's annualized ROA % for the quarter that ended in Dec. 2023 is calculated as:

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=110.7/( (3074.044+3053.528)/ 2 )
=110.7/3063.786
=3.61 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Dec. 2023) net income data. ROA % is displayed in the 30-year financial page.


Blau Farmaceutica  (BSP:BLAU3) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Dec. 2023 )
=Net Income/Total Assets
=110.7/3063.786
=(Net Income / Revenue)*(Revenue / Total Assets)
=(110.7 / 1549.9)*(1549.9 / 3063.786)
=Net Margin %*Asset Turnover
=7.14 %*0.5059
=3.61 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Blau Farmaceutica ROA % Related Terms

Thank you for viewing the detailed overview of Blau Farmaceutica's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Blau Farmaceutica (BSP:BLAU3) Business Description

Traded in Other Exchanges
N/A
Address
Rodovia Raposo Tavares, No. 2833, Km 30.5, Barro Branco, Cotia, SP, BRA, 06705-030
Blau Farmaceutica SA is engaged in the manufacturing, development and commercialization of complex private-label drugs for the institutional segment. The Company's business activities cover institutional and retail segments, and are divided into four units: 1) Biologicals are a heterogeneous class of products that can be produced using raw materials from biological materials and biotechnological procedures. 2) Oncology line is made up of oral and injectable drugs intended for treating cancer, which encompasses a number of therapeutic classes. 3) Specialties line is made up of products that are used in the hospital's daily routine, in the specialized treatments for infectious diseases and special treatments. 4) Others consist of prescription and non-prescription over-the-counter drugs.

Blau Farmaceutica (BSP:BLAU3) Headlines

No Headlines